Estela Rodriguez/X
Jul 4, 2025, 05:05
Estela Rodriguez: More Great News for Patients with Rare Mutations
Estela Rodriguez, Associate Director of Community Outreach- Thoracic Oncology at Sylvester Comprehensive Cancer Center, shared on X:
“More great news for patients with rare mutations: FDA Oncology approved Sunvozertinib (Zegfrovy) oral TKI for EGFR 20ins lung cancer after platinum chemo: a big area of unmet need.
- WU-KONG1B trial
- 200mg once a day
- ORR 46% DOR 11.1 mos
- AEs: Diarrhea (17%), CPK levels (11%), and anemia (3.6%) ILD, ocular tox.”
More posts featuring Estelamari Rodriguez.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 26, 2025, 09:09
Jul 26, 2025, 08:40
Jul 26, 2025, 08:13
Jul 26, 2025, 07:32
Jul 26, 2025, 06:44
Jul 26, 2025, 06:11
Jul 26, 2025, 04:02
Jul 26, 2025, 03:52
Jul 26, 2025, 03:45
Jul 26, 2025, 03:33